Quest Diagnostics (DGX) PT Raised to $182 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $237.77 +0.11%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Morgan Stanley analyst Erin Wright raised the price target on Quest Diagnostics (NYSE: DGX) to $182.00 (from $172.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) Declares $0.86 Quarterly Dividend; 1.4% Yield
- Suzuken Co Ltd (9987:JP) PT Lowered to JPY5,570 at Nomura/Instinet
- Toei co Ltd (9605:JP) PT Raised to JPY6,100 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
